Qule Pharma Private Limited
About Qule Pharma Private Limited
Data last updated:
Qule Pharma Private Limited is a private limited company based in Visakhapatnam, Andhra Pradesh, India, a subsidiary of Aurobindo Antibiotics Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24304AP2020PTC116442. Its GSTIN is 37AAACQ7084K1ZY (Andhra Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Nityananda Reddy Kambam and Santhanam Subramanian.
Its last annual general meeting (AGM) was held on 01 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit 14 Jn Pharma City Plot No 17 Rno.10 11 & 19 20 E Bonangi Vlg, Visakhapatnam, Andhra Pradesh, India – 531021.
As per the financials filed for FY 2023, the company reported a revenue of ₹50,000. For the same year it recorded a net loss of ₹2.97 Cr and EBITDA of -₹80,000 (EBITDA margin -160%).
The company has about 22 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹160 Cr and satisfied charges of ₹210 Cr on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressUnit 14 Jn Pharma City Plot No 17 Rno.10 11 & 19 20 E Bonangi Vlg, Visakhapatnam, Andhra Pradesh, India – 531021
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Qule Pharma Private Limited FY 2025 filings available
Qule Pharma Private Limited reported revenue of ₹50,000 for FY 2023.
Financial Statement Summary of Qule Pharma Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | ₹50,000 | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | -₹80,000 | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | -₹2.97 Cr | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Qule Pharma Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -160% | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Qule Pharma are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Qule Pharma Private Limited
Qule Pharma Private Limited is audited by G P M & Associates for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| G P M & Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Qule Pharma Private Limited
Qule Pharma has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nityananda Reddy Kambam Also directs: Aurobindo Pharma Ltd, Aurobindo Antibiotics Private Limited, Apl Healthcare Limited and 5 more | Director | 01 Dec 2023 | 2 Years 10 Months | Current |
| Santhanam Subramanian Also directs: Apitoria Pharma Private Limited, Lyfius Pharma Private Limited, Engenra Biologics Private Limited and 5 more | Director | 16 Nov 2020 | 5 Years 10 Months | Current |
| Rama Krishna Also directs: Lyfius Pharma Private Limited | Director | 25 Apr 2022 | 4 Years 5 Months | Current |
| Bala Subramanyam Sami Reddy Palle Reddy Also directs: Lyfius Pharma Private Limited, Ecophyto Labs LLP | Additional Director | 14 Nov 2025 | 0 Years 10 Months | Current |
Ownership and Shareholding of Qule Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Qule Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 May 2023 | Others | ₹160 Cr | Open |
| 04 Nov 2024 | State Bank of India | ₹210 Cr | Satisfied |
Total charge records: 2 View all charges
MSME Payment Delays by Qule Pharma Private Limited
Qule Pharma Private Limited has 3 MSME Form 1 returns on record between 2023 and 2024, listing 25 overdue payments to 14 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 14)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Ahlada Clean Room Tech Private Limited | •••• | •••• | •••• |
| G P C Flow Instruments Private Limited | •••• | •••• | •••• |
| Polmon Process Controls Private Limited | •••• | •••• | •••• |
| Jetspray Innovations Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 3 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Qule Pharma Private Limited
Qule Pharma Private Limited has a workforce of 22 employees as of Mar 25, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Qule Pharma Private Limited
Qule Pharma Private Limited has 8 board changes on record since 2020: 4 appointments and 4 cessations. The latest: Bala Subramanyam Sami Reddy Palle Reddy was appointed as Additional Director on 14 Nov 2025.
3 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Qule Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Qule Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Qule Pharma Private Limited
Qule Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAACQ7084K1ZY | Andhra Pradesh | Active | 01 Feb 2022 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Qule Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Qule Pharma Private Limited
Qule Pharma is an active private limited company based in Visakhapatnam, Andhra Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 November 2020 (6+ years old) and is registered under CIN U24304AP2020PTC116442.
Qule Pharma reported revenue of ₹50,000 for FY 2023.
Qule Pharma has 4 current directors:
- Nityananda Reddy Kambam - Director
- Santhanam Subramanian - Director
- Rama Krishna - Director
- Bala Subramanyam Sami Reddy Palle Reddy - Additional Director
Qule Pharma reported a net loss of ₹2.97 Cr and EBITDA of -₹80,000 (EBITDA margin -160%) for FY 2023, as per its filed financial statements.
The GSTIN of Qule Pharma is 37AAACQ7084K1ZY, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Qule Pharma is U24304AP2020PTC116442. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Qule Pharma was incorporated on 16 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Vijayawada.
Bala Subramanyam Sami Reddy Palle Reddy was appointed as Additional Director on 14 Nov 2025. Nityananda Reddy Kambam ceased to be Director Appointed In Casual Vacancy on 27 Dec 2023. Nityananda Reddy Kambam was appointed as Director on 01 Dec 2023. Qule Pharma has 8 board changes on record in total.
Qule Pharma has 3 MSME Form 1 returns on record between 2023 and 2024, listing 25 overdue payments to 14 micro and small suppliers. The latest return was filed on 30 Apr 2024.
The registered office of Qule Pharma is at Unit 14 Jn Pharma City Plot No 17 Rno.10 11 & 19 20 E Bonangi Vlg, Visakhapatnam, Andhra Pradesh, India – 531021.
Qule Pharma has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh.